Success Metrics

Clinical Success Rate

75.0%

Based on 3 completed trials

Completion Rate

75%(3/4)

Active Trials

1(17%)

Results Posted

33%(1 trials)

Terminated

1(17%)

Phase Distribution

Ph not_applicable

33%

Ph phase_2

17%

Ph phase_4

17%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 2Efficacy & side effects

1(25.0%)

Phase 4Post-market surveillance

1(25.0%)

N/ANon-phased studies

2(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(3)

Terminated(1)

Other(1)

Detailed Status

Completed3

Terminated1

unknown1

Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

75.0%

Most Advanced

Phase 4

Trials by Phase

Phase 21 (25.0%)

Phase 41 (25.0%)

N/A2 (50.0%)

Trials by Status

terminated117%

unknown117%

completed350%

active_not_recruiting117%

Recent Activity

1 active trials

Showing 5 of 6

active_not_recruitingphase_2

Clinical Trials (6)

Showing 6 of 6 trials

NCT07541976Phase 2

Comparative Evaluation of Three Different Pulpotomy Agents in Primary Molars

Active Not Recruiting

NCT07120321Not Applicable

Pulpotomy Materials in Primary Molars

Completed

NCT05545527

Neuroimaging Ancillary Study

Completed

NCT05358509Phase 4

Reducing Anemia in Pregnancy in India: the RAPIDIRON Trial

Completed

NCT05504863

RAPIDIRON Trial Follow-up Study: RAPIDIRON-KIDS Study

Unknown

NCT02783911Not Applicable

Comparison of Mineral Trioxide Aggregate (MTA) & Ferric Sulfate (FS) Pulpotomies

Terminated

All 6 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 6